ASX cannabis share Cronos has soared 80% in a month. What's going on?

This cannabis share has been on fire this month…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been a stunning few weeks for the Cronos Australia Ltd (ASX: CAU) share price.

Since this time last month, the medicinal cannabis company's shares have risen over 80%.

This led to the Cronos Australia share price reaching a record high of 75 cents earlier today.

Back view of a man lifting hish hands high in front of hemp plants grown for cannabis.

Image source: Getty Images

Why is the Cronos Australia share price on fire this month?

While the company released a positive update last week which boosted its shares, the majority of the gains were made earlier in the month.

The catalyst for that appears to have been a bullish broker note out of Bell Potter.

According to the note from 5 September, the broker initiated coverage on the company's shares with a buy rating and 60 cents price target.

At the time, the Cronos Australia share price was fetching 46 cents, so this implied potential upside of 30% for investors.

Why is Bell Potter bullish?

Bell Potter explained that its bullish view was based largely on the company's leadership position in medicinal cannabis distribution. It commented:

Cronos Australia is a medicinal cannabis company that is the market leader in distribution to pharmacies and provides patient consulting services through its clinic business. The key driver for the impressive growth in the past 24 months has been the CanView platform which provides the widest range of medicinal cannabis products compared to competitors (Anspec, Health House).

In addition, Bell Potter points out that Cronos Australia is profitable and even pays a dividend. That makes it the only one of its kind in the Australian cannabis industry. It explained:

We initiate coverage on Cronos with a Buy recommendation. We expect the momentum observed in FY22 to continue into FY23 and translate into strong revenue and earnings growth. Cronos is currently the only profitable dividend paying medicinal cannabis company on the ASX and the valuation does not appear demanding relative to the expected growth.

Though, with the Cronos Australia share price now trading higher than Bell Potter's valuation, it's worth considering that it could have peaked for the time being.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Cannabis Shares

An older farmer wearing a checkered shirt and a straw hat stands in a green field of cannabis plants growing up to waist level as he smiles while thinking about the outlook for ASX cannabis shares in FY23
Cannabis Shares

Buying ASX cannabis stocks? Here's what the Victorian government is considering right now

Victoria became the first state to legalise medicinal cannabis in 2016. Now the government is playing catch-up with other laws.

Read more »

A graphic showing a rising share price in medical cannabis shares
Cannabis Shares

Why did this ASX 300 cannabis share just rocket 12%?

Incannex is going to make its own pharmaceutical-grade psilocybin drug for clinical trials and potential commercial use.

Read more »

A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
Cannabis Shares

Why did this ASX cannabis share just rocket 46%?

This cannabis share has been given a major boost by regulators...

Read more »

cannabis farmer in the fields checking the crops
Cannabis Shares

Looking to buy ASX cannabis shares right now? You'll want to watch this

Cannabis stocks on the ASX have been hit by similar headwinds facing cannabis companies the world over.

Read more »

An older farmer wearing a checkered shirt and a straw hat stands in a green field of cannabis plants growing up to waist level as he smiles while thinking about the outlook for ASX cannabis shares in FY23
Cannabis Shares

Why is everyone talking about ASX cannabis shares all of a sudden?

Recent news out of the US may rekindle investor interest in cannabis stocks.

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Cannabis Shares

Why are these 2 ASX cannabis shares booming all of a sudden?

It wasn’t all too long ago that most companies involved in the cultivation and sale of medicinal or recreational marijuana…

Read more »

two men in formal business clothing closely inspect a bud from a cannabis crop.
Broker Notes

Bell Potter slaps buy rating on this profitable, dividend-paying ASX cannabis share

This cannabis share is smoking the market on Monday...

Read more »

A man in a horse head mask and suit jumps for joy on a beach.
Earnings Results

Guess which company just became the first ASX cannabis share to pay a dividend

We take a a look at why this ASX cannabis share is having such a good day.

Read more »